Skip to Main Content

Paper Details

Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial.
Genome Med
17
2021
Author NameAffiliation
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Sung Tae KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Jason K SaKorea University College of Medicine
Kyung KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Kyoung-Mee KimSamsung Medical Center, Sungkyunkwan University School of Medicine
Jeeyun LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
  • 1 - 6

Datasets

Release 1.2